Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies granted restricted stock units and options to four new employees as inducements to join the company. The grants include 714,700 RSUs and options to purchase 468,600 shares, issued under the 2023 Inducement Plan in compliance with Nasdaq Listing Rule 5635(c)(4).
Key figures
- Rsu shares granted
- 714700
- Total new employees
- 4
- Option exercise price
- 5.97
- Option shares granted
- 468600
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.